Immunotherapy for non-small cell lung cancer: From clinical trials to real-world practice

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	202-207
Number of pages	6
Journal	Translational Lung Cancer Research
Volume	8
Issue number	3
DOIs	https://doi.org/10.21037/tlcr.2018.09.15
State	Published - Jun 1 2019

ASJC Scopus subject areas

@article{3774f5a774f44b72a79f8ef10140e1be,

title = "Immunotherapy for non-small cell lung cancer: From clinical trials to real-world practice",

author = "Sawsan Rashdan and Gerber, {David E.}",

note = "Funding Information: Funding: This study was supported in part by a National",

year = "2019",

month = jun,

day = "1",

doi = "10.21037/tlcr.2018.09.15",

language = "English (US)",

volume = "8",

pages = "202--207",

journal = "Translational Lung Cancer Research",

issn = "2226-4477",

publisher = "Society for Translational Medicine (STM)",

number = "3",

}

TY - JOUR

T1 - Immunotherapy for non-small cell lung cancer

T2 - From clinical trials to real-world practice

AU - Rashdan, Sawsan

AU - Gerber, David E.

N1 - Funding Information: Funding: This study was supported in part by a National

PY - 2019/6/1

Y1 - 2019/6/1

UR - http://www.scopus.com/inward/record.url?scp=85068410907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068410907&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2018.09.15

DO - 10.21037/tlcr.2018.09.15

M3 - Review article

C2 - 31367533

AN - SCOPUS:85068410907

VL - 8

SP - 202

EP - 207

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

SN - 2226-4477

IS - 3

ER -